| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 210.31B | 218.10B | 210.86B | 208.30B | 212.38B | 220.13B |
| Gross Profit | 129.55B | 137.20B | 129.23B | 126.34B | 125.70B | 129.31B |
| EBITDA | 19.02B | 24.17B | 20.32B | 16.19B | 16.85B | 18.17B |
| Net Income | 8.54B | 11.54B | 8.80B | 5.84B | 7.42B | 10.20B |
Balance Sheet | ||||||
| Total Assets | 317.11B | 340.14B | 312.46B | 300.69B | 285.59B | 254.18B |
| Cash, Cash Equivalents and Short-Term Investments | 32.01B | 34.95B | 36.21B | 37.40B | 32.28B | 29.57B |
| Total Debt | 137.55B | 150.04B | 130.26B | 119.55B | 111.34B | 84.32B |
| Total Liabilities | 177.37B | 188.68B | 170.80B | 164.50B | 159.15B | 135.13B |
| Stockholders Equity | 139.39B | 151.34B | 141.31B | 135.19B | 125.50B | 118.27B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -14.84B | -5.34B | -4.01B | -21.76B | -9.47B |
| Operating Cash Flow | 0.00 | 18.46B | 9.69B | 12.77B | 8.24B | 7.15B |
| Investing Cash Flow | 0.00 | -32.29B | -17.79B | -14.40B | -29.92B | -17.03B |
| Financing Cash Flow | 0.00 | 13.91B | 6.72B | 5.97B | 23.53B | 8.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥121.14B | 19.39 | ― | 1.54% | 3.97% | -16.37% | |
69 Neutral | ¥905.39B | 22.31 | 49.14% | 2.82% | 7.15% | 6.34% | |
69 Neutral | ¥56.85B | 16.49 | ― | 4.27% | 5.38% | -34.97% | |
62 Neutral | ¥90.21B | 7.25 | 6.96% | 2.98% | 3.43% | 31.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥46.42B | -18.98 | ― | 3.31% | 0.69% | -377.37% | |
46 Neutral | ¥1.64T | -21.05 | -21.14% | ― | 10.70% | 36.82% |